Colorectal cancer: Review of signaling pathways and associated therapeutic strategies

被引:8
|
作者
Leiphrakpam, Premila D. [1 ,2 ]
Rajappa, Senthil J. [3 ]
Krishnan, Mridula [4 ]
Batra, Rishi [5 ]
Murthy, Shilpa S. [6 ]
Are, Chandrakanth [1 ,2 ,7 ]
机构
[1] Univ Nebraska Med Ctr, Coll Med, Grad Med Educ, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Surg Oncol, Omaha, NE USA
[3] Basavatarakam Indo Amer Canc Hosp, Med Oncol, Hyderabad, Telangana, India
[4] Univ Nebraska Med Ctr, Coll Med, Dept Internal Med, Div Oncol & Hematol, Omaha, NE USA
[5] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Gen Surg, Omaha, NE USA
[6] Mem Sloan Kettering Canc Ctr, Div Surg Oncol, Global Canc Dispar Initiat, New York, NY USA
[7] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Surg Oncol, Omaha, NE 68198 USA
关键词
biomarkers; colorectal cancer; targeted therapy; RANDOMIZED PHASE-III; FOLFIRI PLUS BEVACIZUMAB; MOLECULAR SUBGROUP ANALYSES; FACTOR-BETA RECEPTOR; KRAS WILD-TYPE; OPEN-LABEL; 1ST-LINE TREATMENT; FOLFOXIRI PLUS; DOUBLE-BLIND; MAINTENANCE TREATMENT;
D O I
10.1002/jso.27295
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor profiling and targeted therapy revolutionized the treatment strategies of metastatic colorectal cancer (mCRC) in the last decade. The heterogeneity of CRC tumors plays a critical role in the development of treatment resistance, which underscores the need to understand the molecular mechanism involved in CRC to develop novel targeted therapeutic strategies. This review provides an overview of the signaling pathways driving CRC, the existing targeted agents, their limitations, and future trends.
引用
收藏
页码:1277 / 1295
页数:19
相关论文
共 50 条
  • [41] Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma
    Vallini, Giulia
    Calabrese, Laura
    Canino, Costanza
    Trovato, Emanuele
    Gentileschi, Stefano
    Rubegni, Pietro
    Tognetti, Linda
    CELLS, 2023, 12 (21)
  • [42] Emerging therapeutic strategies targeting bone signaling pathways in periodontitis
    Valverde, Araceli
    George, Anne
    Nares, Salvador
    Naqvi, Afsar R.
    JOURNAL OF PERIODONTAL RESEARCH, 2025, 60 (02) : 101 - 120
  • [43] Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
    Wang, Kexin
    Li, Yanhua
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [44] The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
    Hon, Kha Wai
    Abidin, Syafiq Asnawi Zainal
    Othman, Iekhsan
    Naidu, Rakesh
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [45] Therapeutic strategies targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer
    Zhou, Yi
    Wu, Shuang
    Qu, Fan-Jie
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (06) : 2362 - 2379
  • [46] Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities
    Zhou Donger
    Zheng Lei
    中华医学杂志英文版, 2024, 137 (06)
  • [47] Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities
    Zhou, Donger
    Zheng, Lei
    CHINESE MEDICAL JOURNAL, 2024, 137 (06) : 638 - 650
  • [48] Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer (Review)
    Niiro, Emiko
    Morioka, Sachiko
    Iwai, Kana
    Yamada, Yuki
    Ogawa, Kenji
    Kawahara, Naoki
    Kobayashi, Hiroshi
    BIOMEDICAL REPORTS, 2018, 8 (03) : 215 - 223
  • [49] Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies
    Wang, Kang
    Wang, Yun
    Yin, Kai
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (05)
  • [50] A Review on Notch Signaling and Colorectal Cancer
    Tyagi, Ashish
    Sharma, Arun K.
    Damodaran, Chendil
    CELLS, 2020, 9 (06)